Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6241586B2 - - Google Patents
[go: Go Back, main page]

JPS6241586B2 - - Google Patents

Info

Publication number
JPS6241586B2
JPS6241586B2 JP2767380A JP2767380A JPS6241586B2 JP S6241586 B2 JPS6241586 B2 JP S6241586B2 JP 2767380 A JP2767380 A JP 2767380A JP 2767380 A JP2767380 A JP 2767380A JP S6241586 B2 JPS6241586 B2 JP S6241586B2
Authority
JP
Japan
Prior art keywords
dimethoxy
formula
hydroxy
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2767380A
Other languages
Japanese (ja)
Other versions
JPS56123931A (en
Inventor
Atsuro Terajima
Norihiko Tanno
Kenji Koga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUMITOMO SEIYAKU KK
Original Assignee
SUMITOMO SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUMITOMO SEIYAKU KK filed Critical SUMITOMO SEIYAKU KK
Priority to JP2767380A priority Critical patent/JPS56123931A/en
Priority to EP81300754A priority patent/EP0035355B1/en
Priority to DE8181300754T priority patent/DE3163452D1/en
Priority to US06/238,136 priority patent/US4338255A/en
Priority to CA000372229A priority patent/CA1142950A/en
Publication of JPS56123931A publication Critical patent/JPS56123931A/en
Priority to US06/363,048 priority patent/US4418218A/en
Publication of JPS6241586B2 publication Critical patent/JPS6241586B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は下記式(1) で示される2―アセチル―5,8―ジメトキシ―
1,2,3,4―テトラヒドロ―2―ナフトール
の新規製造法である。 さらに詳しくは本発明は下記式() で示される2―アセチル―5,8―ジメトキシ―
3,4―ジヒドロナフタリンのカルボニル(〓
CO)部を還元し、下記式() で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―3,4―ジヒドロナフタリンを
得、次いでこの化合物の1位2位間の二重結合を
エポキシ化し、一般式() で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―1,2―エポキシ―1,2,
3,4―テトラ―ヒドロナフタリンを得、次いで
この化合物の1,2―エポキシ部
The present invention is expressed by the following formula (1) 2-acetyl-5,8-dimethoxy represented by
This is a new method for producing 1,2,3,4-tetrahydro-2-naphthol. More specifically, the present invention is based on the following formula () 2-acetyl-5,8-dimethoxy represented by
Carbonyl of 3,4-dihydronaphthalene (〓
CO) part is reduced and the following formula () 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-3,4-dihydronaphthalene was obtained, and then the double bond between the 1st and 2nd positions of this compound was epoxidized to give the general formula () 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-1,2-epoxy-1,2,
3,4-tetra-hydronaphthalene is obtained, and then the 1,2-epoxy part of this compound is

【式】を還元し、下記式() で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―1,2,3,4―テトラヒドロ
―2―ナフトールを得、次いでこの化合物の1′―
ヒドロキシ部(〓CHOH)を酸化することを特
徴とする前記式(1)で示される2―アセチル―5,
8―ジメトキシ―1,2,3,4―テトラヒドロ
―2―ナフトールの新規製造法である。ここで化
合物(1)は2(R)一体、2(S)一体またはそれ
らの混合物を、化合物()は1′(S)一体、
1′(R)一体またはそれらの混合物を、化合物
()は1′(S)、1(S)、2(S)一体、
1′(S)、1(R)、2(R)一体、1′(R)、1
(R)、2(R)一体、1′(R)、(S)、2(S)
一体または前記4種の異性体の任意の組合せの混
合物を、化合物()は1′(S)、2(R)一
体、1′(S)、2(S)一体、1′(R)、2(S)
一体、1′(R)、2(R)一体または前記4種の
異性体の任意の組合せの混合物を含む。 なお(→→→―(1))については次の関
係がある。 また本発明は前記式()で示される2―アセ
チル―5,8―ジメトキシ―3,4―ジヒドロナ
フタリンのカルボニル(〓CO)部を(−)―1
(R)、2(S)―N―アルキルまたはアルアルキ
ル置換エフニドリンとN―モノアルキルまたはア
リール置換アニリン類とで部分分解したリチウム
アルミニウムトビリドで不斉還元し、下記式
(′) で示される(−)―2―(1′(S)―ヒドロキシ
エチル)―5,8―ジメトキシ―3,4―ジヒド
ロナフタリンを得、次いでこの化合物の1位2位
間の二重結合をエポキシ化し、下記式(′) で示される2(S)―(1′(S)―ヒドロキシ)
エチル―5,8―ジメトキシ―1(S)、2
(S)―エポキシ―1,2,3,4―テトラヒド
ロナフタリンを得、次いでこの化合物の1,2―
エポキシ部
Reduce [formula] and the following formula () 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol is obtained, and then the 1'-
2-acetyl-5 represented by the above formula (1), which is characterized by oxidizing the hydroxy moiety (–CHOH),
This is a new method for producing 8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol. Here, compound (1) is 2(R) monolithic, 2(S) monolithic or a mixture thereof, and compound () is 1′(S) monolithic,
1'(R) or a mixture thereof, compound () is 1'(S), 1(S), 2(S),
1'(S), 1(R), 2(R) together, 1'(R), 1
(R), 2 (R) integral, 1' (R), (S), 2 (S)
The compound () is 1'(S), 2(R) monolithic, 1'(S), 2(S) monolithic, 1'(R), monolithic or a mixture of any combination of the above four isomers. 2(S)
It includes monolithic, 1'(R), 2(R) monolithic, or a mixture of any combination of the above four isomers. Regarding (→→→-(1)), the following relationship exists. Further, the present invention provides the carbonyl (〓CO) moiety of 2-acetyl-5,8-dimethoxy-3,4-dihydronaphthalene represented by the above formula () to (-)-1
(R), 2(S)-N-alkyl- or aralkyl-substituted efnidoline and N-monoalkyl- or aryl-substituted anilines are subjected to asymmetric reduction with lithium aluminum tobilide partially decomposed, and the following formula (') is obtained. (-)-2-(1'(S)-hydroxyethyl)-5,8-dimethoxy-3,4-dihydronaphthalene represented by , and the following formula (′) 2(S)-(1'(S)-hydroxy) represented by
Ethyl-5,8-dimethoxy-1(S),2
(S)-epoxy-1,2,3,4-tetrahydronaphthalene was obtained, and then the 1,2-
Epoxy part

【式】を還元し、下記式 (′) で示される(−)―2(R)―(1′(S)―ヒド
ロキシ)エチル―5,8―ジメトキシ―1,2,
3,4―テトラヒドロ―2(R)―ナフトールを
得、次いでこの化合物の1′―ヒドロキシ部(〓
CHOH)を酸化することを特徴とする下記式(1) で示される(−)―2(R)―アセチル―5,8
―ジメトキシ―1,2,3,4―テトラヒドロ―
2(R)―ナフトールの新規製造法である。 本発明により得られる化合物(1)、特に(−)―
2(R)―アセチル―5,8―ジメトキシ―1,
2,3,4―テトラヒドロ―2(R)―ナフトー
ル(1′)は、顕著な制がん作用により最近注目さ
れているアントラサイクリン系抗生物質、アドリ
アマイシン(2)、ダウノルビシン(3)等の合成原料と
して極めて有用な化合物である(F.Arcamone,
Lloydia,40,45(1977).T.R.Kelly“Synthetic
Approaches to Anthracycline Antibintics,”in
“Annual Reports in Medicinal Chemistry,”
Am Chem Soc.,1979)。すなわち1′からは、2
および3のアグリコンであるアドリアマイシノン
(4)およびダウノマイシノン
Reduce [formula] to the following formula (') (-)-2(R)-(1'(S)-hydroxy)ethyl-5,8-dimethoxy-1,2,
3,4-tetrahydro-2(R)-naphthol was obtained, and then the 1'-hydroxy moiety (〓
The following formula (1) is characterized by oxidizing CHOH) (-)-2(R)-acetyl-5,8 represented by
-dimethoxy-1,2,3,4-tetrahydro-
This is a new method for producing 2(R)-naphthol. Compound (1) obtained by the present invention, especially (-)-
2(R)-acetyl-5,8-dimethoxy-1,
2,3,4-tetrahydro-2(R)-naphthol (1') is a compound used in the synthesis of adriamycin (2), daunorubicin (3), etc., which are anthracycline antibiotics that have recently attracted attention due to their remarkable anticancer effects. It is an extremely useful compound as a raw material (F.Arcamone,
Lloydia, 40 , 45 (1977). TRKelly“Synthetic
Approaches to Anthracycline Antibintics,”in
“Annual Reports in Medicinal Chemistry,”
Am Chem Soc., 1979). That is, from 1′, 2
and adriamycinone, an aglycone of 3.
(4) and daunomycinone

【表】 〜
【table】 ~

【表】 5)からの2および3の合成ルートも確立してい
る(C,M,Wong,etal,Can.J.Chem,49
2712(1971)。C,M,Wong,etalIbid51
466(1973)。T,H,Smith,etal,J.Org.
Chem,42,3653(1977)。)。2および3は多用
すると場合によつては心臓障害を起すことが知ら
れており、この心臓障害等の副作用の少ない非天
然型アントラサイクリンとしては、4―デメトキ
シアドリアマイシン(6)および4―デメトキシダウ
ノルビシン(7)が優れた薬理作用を有する制がん剤
として開発されているが、6および7も1′を出発
物質に用いて合成されている(F,Arcamone,
etal,Cancer Treat.Rep.60,829(1976)。F,
Arcamone,etalGerman Offen,261785。F,
Arcamone,Lloydia 40,45(1977)。)。 以上述べたごとく、天然型および非天然型アン
トラサイクリンの製造において、本発明の目的化
合物(1)、特に1′は光学活性体の製造原料として極
めて重要な化合物であるが、その製造は2,5―
ジメトキシベンゾアルデヒドから製造する方法で
あり、特に光学活性体1′の製造法はそのようにし
て製造した1′に対応するラセミ体(C,M,
Wong,etal,Can J,Chem,49,2712
(1971)。C,M,Wong,etal Ibid51,466
(1973)。)を光学活性α―フエニルエチルアミン
を用いて光学分割する方法(F,Arcamo―ne,
etal,German Offen,2601785)、または(S)
―プロリンと5,8―ジメトキシ―3,4―ジヒ
ドロ―2―ナフトエ酸(8)から得られるN―α,β
―不飽和アシル―(S)―プロリンの不斉ブロム
ラクトン化反応を利用する方法(S,
Terashima,etal,Chem,Pharm,Bull
(Tokyo),27,2351(1979)。)が試みられている
にすぎない。 本発明者らは、かかる状況下2―アセチル―
5,8―ジメトキシ―3,4―ジヒドロナフタリ
ン〔〕を用いて本発明目的化合物を効率よく製
造する方法を開発し本発明を完成したのである。
以下に本発明を詳述する。 本発明製造法における第一段階である式()
の化合物のカルボニル部(〓CO)を還元し式
()の化合物を得る方法であるが、本方法では
ケトン(〓CO)を第二アルコール(〓CHOH)
に還元する通常の方法が採用される。すなわち還
元剤としてナトリウムボロヒドリド、亜鉛ボロヒ
ドリド、リチウムアルミニウムヒドリド、リチウ
ム―トリ―t―ブトキシアルミニウムヒドリド、
ナトリウム、ビス(メトキシエトキシ)アルミニ
ウムヒドリド等が通常用いられ、通常エーテル、
テトラヒドロフラン、ジメトキメタン、ジメトキ
シエタン等のエーテル系溶媒、トルエン等の芳香
族炭化水素系溶媒等の溶媒中−70〜+25℃で1〜
4時間反応させる。 なお、還元剤として(−)―1(R)、2
(S)―N―アルキルまたはアルアルキル置換エ
フエドリンとN―モノアルキルまたはアリール置
換アニリン類とで部分分解したリチウムアルミニ
ウムヒドリドを用いると光学活性な化合物
(′)が不斉収率良く得られる。通常1当量の
(−)―1(R)、2(S)―N―メチルエフエド
リン(K,Nakajima,日本化学雑誌81,1476
(1960))と2当量のN―エチルアニリンで部分分
解したリチウムアルミニウムヒドリドを用い−78
℃で3時間還元し、反応成績体から中性部を分離
すると、粗製の化合物(′)が得られる。ま
た、反応成績体の塩基性部からは、(−)―1
(R)、2(S)―N―メチルエフエドリンとN―
エチルアニリンが定量的に回収される。 粗製の化合物(′)は、ヘキサンから再結晶
すると、光学純度100%の化合物(′)mp88―
89℃、〔α〕20 ―20.5゜(C=1.07エタノール)が
得られる。 (−)―1(R)、2(S)―N―アルキルま
たはアルアルキル置換エフエドリンとしては
(−)―1(R)、2(S)―N―メチルエフエド
リン以外に、(−)―1(R)、2(S)―N―エ
チルエフエドリン(O.Cervinka,etal,Coll
Czech Chem,Comm,32,3897(1967)。),
(−)―1(R),2(S)―N―プロピルエフエ
ドリン、(−)―1(R)、2(S)―N―イソブ
チルエフエドリン、(+)―1(R)、2(S)―
N―ベンジルエフエドリン(S,Yamada,
etal,Yakugaku Zasshi,in press)が使用でき
るが、(−)―1(R)、2(S)―N―メチルエ
フエドリンが最も良好な不斉源である。またN―
モノアルキルまたはアリール置換アニリン類とし
てN―エチルアニリン以外に、N―メチルアニリ
ン、N―プロピルアニリン、N―イソプロピルア
ニリン、N―ブチルアニリン、N―イソブチルア
ニリン、N―エチル―3,5―ジメチルアニリ
ン、N―エチル―2,6―ジメチルアニリン、ジ
フエニルアミン、カルバゾール等が使用できる
が、化合物(′)の不斉収率はN―エチルアニ
リンを用いた場合に最大であつた。また、N―t
―ブチルアニリン、ピロリジン、ピペリジン、モ
ルホリン、ピロール、イミダゾール、ベンツトリ
アゾール等をN―エチルアニリンに代えて使用し
た場合には、還元反応は進行しないか、また、進
行しても不斉収率は低くかつた。 (−)―1(R)、2(S)―N―アルキルま
たはアルアルキル置換エフエドリンとN―モノア
ルキルまたはアリールアニリン類の比率は、上記
の1:2以外でも行いえるが、不斉源を効率よく
用いる面からは1:2の比率が望ましい。 また以上の場合程効率良くないが、次の場合も
不斉還元できる。すなわち、化合物()を3当
量の(−)―1(R)、2(S)―N―アルキル
エフエドリン、たとえば(−)―1(R)、2
(S)―N―メチルエフエドリンで部分分解した
リチウムアルミニウムヒドリド(S,Yamada,
etal,Chem,pharm,Bull,(Tokyo),25,1273
(1977)。)で不斉還元した場合には、光学純度15
%の化合物(′)が収率34%で、1当量の
(−)―1(R)、2(S)―N―アルキルエフエ
ドリンたとえば(−)―1(R)、2(S)―N
―メチルエフエドリンと2当量のm―キシレノー
ルで部分分解したリチウムアルミニウムヒドリド
(J,P,Vigneron,etal,Tetrahedron,32
939(1976)。)で不斉還元した場合には、光学純
度13%の化合物(′)の対掌体が収率68%で、
また、1当量の(S)―2―アニリノメチルピロ
リジンで部分分解したリチウム.アルミニウム.
ヒドリド(T,Mukai yama,etalBull,Chem,
Soc,Japan,51,1869(1978)。)で不斉還元し
た場合には、光学純度54%の化合物(′)が収
率60%で得られた。 第二段階の1位2位二重結合のエポキシ化反応
であるが、この反応は通常の二重結合のエポキシ
化反応
[Table] Synthetic routes for 2 and 3 from 5) have also been established (C, M, Wong, etal , Can.J.Chem, 49 ,
2712 (1971). C. M. Wong, etal , Ibid ., 51 .
466 (1973). T, H, Smith, etal , J.Org.
Chem, 42 , 3653 (1977). ). 2 and 3 are known to cause heart damage in some cases if used frequently, and 4-demethoxyadriamycin (6) and 4-demethoxyadriamycin (6) are non-natural anthracyclines with fewer side effects such as heart damage. Methoxydaunorubicin (7) has been developed as an anticancer drug with excellent pharmacological activity, but 6 and 7 have also been synthesized using 1' as a starting material (F, Arcamone,
etal , Cancer Treat. Rep. 60 , 829 (1976). F,
Arcamone, etal German Offen, 261785. F,
Arcamone, Lloydia 40 , 45 (1977). ). As mentioned above, in the production of natural and non-natural anthracyclines, the object compound (1) of the present invention, especially 1', is an extremely important compound as a raw material for the production of optically active forms. 5-
This is a method for producing optically active compound 1' from dimethoxybenzaldehyde, and in particular, the method for producing optically active substance 1' is a racemic form (C, M,
Wong, etal , Can J, Chem, 49 , 2712
(1971). C, M, Wong, etal Ibid , 51 , 466
(1973). ) using optically active α-phenylethylamine (F, Arcamo-ne,
etal , German Offen, 2601785) or (S)
-N-α,β obtained from proline and 5,8-dimethoxy-3,4-dihydro-2-naphthoic acid (8)
A method using asymmetric bromolactonization reaction of -unsaturated acyl-(S)-proline (S,
Terashima, etal , Chem, Pharm, Bull
(Tokyo), 27 , 2351 (1979). ) is merely being attempted. Under such circumstances, the present inventors discovered that 2-acetyl-
The present invention was completed by developing a method for efficiently producing the object compound of the present invention using 5,8-dimethoxy-3,4-dihydronaphthalene.
The present invention will be explained in detail below. Formula () which is the first step in the production method of the present invention
This method reduces the carbonyl moiety (〓CO) of a compound to obtain a compound of formula (), but in this method, the ketone (〓CO) is converted into a secondary alcohol (〓CHOH).
The usual method of reducing That is, as a reducing agent, sodium borohydride, zinc borohydride, lithium aluminum hydride, lithium-tri-t-butoxyaluminum hydride,
Sodium, bis(methoxyethoxy)aluminum hydride, etc. are usually used, and ether,
In a solvent such as an ether solvent such as tetrahydrofuran, dimethoxymethane, or dimethoxyethane, or an aromatic hydrocarbon solvent such as toluene, at -70 to +25°C from 1 to
Allow to react for 4 hours. In addition, as a reducing agent (-)-1(R), 2
When lithium aluminum hydride partially decomposed with (S)-N-alkyl- or aralkyl-substituted ephedrin and N-monoalkyl- or aryl-substituted anilines is used, the optically active compound (') can be obtained in good asymmetric yield. Usually 1 equivalent of (-)-1(R),2(S)-N-methylefedrine (K, Nakajima, Nippon Kagaku Zasshi 81 , 1476
(1960)) and lithium aluminum hydride partially decomposed with 2 equivalents of N-ethylaniline.
The crude compound (') is obtained by reducing the reaction mixture at °C for 3 hours and separating the neutral part from the reaction product. In addition, from the basic part of the reaction product, (-)-1
(R), 2(S)-N-methylefedrin and N-
Ethylaniline is recovered quantitatively. When the crude compound (′) is recrystallized from hexane, the compound (′) mp88- with 100% optical purity is obtained.
89°C, [α] 20 D -20.5° (C=1.07 ethanol) is obtained. In addition to (-)-1(R), 2(S)-N-methylephedrin, (-)-1(R), 2(S)-N-alkyl or aralkyl-substituted ephedrin includes (-)- 1(R), 2(S)-N-ethylephedrine (O. Cervinka, etal , Coll.
Czech Chem, Comm, 32 , 3897 (1967). ),
(-)-1(R), 2(S)-N-propylephedrin, (-)-1(R), 2(S)-N-isobutylephedrin, (+)-1(R), 2 (S)-
N-benzylephedrin (S, Yamada,
etal , Yakugaku Zasshi, in press), but (-)-1(R),2(S)-N-methylefedrine is the best chiral source. Again N-
In addition to N-ethylaniline, monoalkyl- or aryl-substituted anilines include N-methylaniline, N-propylaniline, N-isopropylaniline, N-butylaniline, N-isobutylaniline, and N-ethyl-3,5-dimethylaniline. , N-ethyl-2,6-dimethylaniline, diphenylamine, carbazole, etc. can be used, but the asymmetric yield of compound (') was highest when N-ethylaniline was used. Also, N-t
- When butylaniline, pyrrolidine, piperidine, morpholine, pyrrole, imidazole, benztriazole, etc. are used in place of N-ethylaniline, the reduction reaction does not proceed, or even if it does proceed, the asymmetric yield is low. Katta. The ratio of (-)-1(R), 2(S)-N-alkyl or aralkyl-substituted ephedrin to N-monoalkyl or arylaniline may be other than the above 1:2, but the chiral source may be From the viewpoint of efficient use, a ratio of 1:2 is desirable. Asymmetric reduction is also possible in the following case, although it is not as efficient as the above case. That is, compound () is converted into 3 equivalents of (-)-1(R),2(S)-N-alkylephedrin, e.g. (-)-1(R),2
Lithium aluminum hydride (S, Yamada,
etal , Chem, pharm, Bull, (Tokyo), 25 , 1273
(1977). ), the optical purity is 15.
% of compound (') in a yield of 34% and 1 equivalent of (-)-1(R), 2(S)-N-alkylephedrine such as (-)-1(R), 2(S)- N
- Lithium aluminum hydride partially decomposed with methyl ephedrin and 2 equivalents of m-xylenol (J, P, Vigneron, etal , Tetrahedron, 32 ,
939 (1976). ), the enantiomer of compound (') with an optical purity of 13% was obtained in a yield of 68%,
In addition, lithium partially decomposed with 1 equivalent of (S)-2-anilinomethylpyrrolidine. aluminum.
Hydride (T, Mukai yama, etal Bull, Chem,
Soc, Japan, 51 , 1869 (1978). ), compound (') with optical purity of 54% was obtained in 60% yield. The second step is the epoxidation reaction of the 1st and 2nd double bonds, but this reaction is a normal double bond epoxidation reaction.

【式】が用いられる。エポ キシ化剤としては通常t―ブチルハイドロパーオ
キシド、クメンハイドロパーオキシド等をモリブ
デナム ジオキシアセチルアセトネート(MoO2
(acac)2)、バナジウム オキシアセチルアセトネ
ート(VO(acac)2)等の触媒存在下に用いる試薬
(K,B,Scharpless,etal,J,Am Chem
Soc,956136(1973)、H.Yamamoto,etal
Bull,Chem Soc.Japan 52,1701(1979)。)、
過安息香酸、m―クロロ過安息香酸、過酢酸等の
有機過酸が挙げられる。通常ベンゼン、トルエン
等の芳香族炭化水素系溶媒、クロロホルム、メチ
レンクロライド等のハロゲン化炭化水素系溶媒中
−20〜+25℃で30分間〜4時間反応させる。 本反応で得られる化合物()は不安定なの
で、通常精製することなく、精製のまま直ちに次
の工程に付される。 光学純度100%の化合物(′)をt―ブチルハ
イドロパーオキシドをバナジウムオキシアセチル
アセトネートの触媒存在下に用いる試薬等で、ベ
ンゼン等の溶媒中酸化すると光学活性な化合物
(′)を得る。通常、その1(R)、2(R)ア
イソマー少量と共に得られ(実施例参照)、この
混合物は不安定なオイルなので、精製することな
く直ちに次の工程に付される。 第三段階の化合物()の1,2―エポキシ部
の還元反応であるが、この反応は通常のエポキシ
[Formula] is used. The epoxidizing agent is usually t-butyl hydroperoxide, cumene hydroperoxide, etc., molybdenum dioxyacetylacetonate (MoO 2
(acac) 2 ), vanadium oxyacetylacetonate (VO(acac) 2 ), and other reagents used in the presence of catalysts (K, B, Scharpless, etal , J, Am Chem
Soc, 95 6136 (1973), H. Yamamoto, etal ,
Bull, Chem Soc. Japan 52 , 1701 (1979). ),
Examples include organic peracids such as perbenzoic acid, m-chloroperbenzoic acid, and peracetic acid. The reaction is usually carried out at -20 to +25°C for 30 minutes to 4 hours in an aromatic hydrocarbon solvent such as benzene or toluene, or a halogenated hydrocarbon solvent such as chloroform or methylene chloride. Since the compound () obtained in this reaction is unstable, it is usually directly subjected to the next step without being purified. Compound (') with 100% optical purity is oxidized with a reagent such as t-butyl hydroperoxide in the presence of a catalyst of vanadium oxyacetylacetonate in a solvent such as benzene to obtain optically active compound ('). It is usually obtained together with small amounts of the 1(R) and 2(R) isomers (see Examples), and since this mixture is an unstable oil, it is immediately subjected to the next step without purification. The third step is the reduction reaction of the 1,2-epoxy moiety of compound (), but this reaction

【式】のアルコールalcohol of [formula]

【式】への還元反 応が用いられる。還元剤として通常リチウムアル
ミニウムヒドリド、ナトリウムビス(メトキシエ
トキシ)アルミニウムヒドリド等を用いテトラヒ
ドロフラン等のエーテル系溶媒、ベンゼン、トル
エン等の芳香族炭化水素系溶媒等の溶媒中、−20
〜+25℃、1〜4時間で反応させる。 光学活性な化合物(′)を用いて本還元反応
に付すと、光学活性な化合物(′)を得る。通
常1(R)、2(R)―アイソマー少量の混入し
た化合物(′)を用いて本還元反応を行うと2
(S)―エピマーの混入した化合物(′)を得る
が、この粗製物はカラムクロマトグラフイー、再
結晶等の手段で精製できる。また2(S)―エピ
マーの混入した混合物のままで次の酸化反応に付
すこともできる。 第四段階の化合物()の1′―ヒドロキシ部
(〓CHOH)を酸化する工程であるが本酸化反応
は通常第2アルコールをケトンに酸化する(〓
CHOH→〓C=O)方法が用いられる。酸化剤
として通常クロム酸―硫酸、ピリジニウムクロロ
クロメート(E,J,Corey,etal
Tetrahedron Letters,1975,2647。)、ジメチル
スルホキシド―ジシクロヘキシルカルボジイミド
ートリフルオロ酢酸―ピリジン(K,E,
Pfitzner,etal,J,Am Chem Soc,87
5661,5670(1965)。)、炭酸銀―セライト、
(Fetizon試薬)(Fetizon,etal,J,Org.
Chem,36,1339(1971)。)等が用いられ、通常
アセトン、ジクロロメタン、ジメチルスルホキシ
ド、ベンゼン等の溶媒中、0〜80℃で1〜24時間
で反応させる。 光学活性な化合物(′)を用いてFetizon試薬
で酸化すると光学活性な本発明の化合物(1′)が
得られる。前述の如き2(S)―エピマーの混入
した化合物(′)を用いるときは、化合物
(1′)の2(S)―エピマーの混入した化合物
(1′)が得られる。 以上述べたごとく、本発明によれば、2―アセ
チル―5,8―ジメトキシ―3,4―ジヒドロナ
フタリン()から工業的にも可能な簡単な反応
操作により、アントラサイクリン系抗生物質を合
成する際極めて有用な出発物質となりうる2―ア
セチル―5,8―ジメトキシ―1,2,3,4―
テトラヒドロ―2―ナフトール(1)が製造できる。
特に化合物(1)の光学活性体(1′)が光学純度100
%で製造し得る。なお化合物()は5,8―ジ
メトキシ―3,4―ジヒドロ―2―ナフトエ酸
(S,Terashi―ma,Chem,Pharm,Bull,
(Tokyo),27,2351(1979)。)から容易に製造で
きる。すなわち、本発明は、工業的見地からも1
の優れた合成法である。 以下に本発明の態様を実施例で示す。 参考例 2―アセチル―5,8―ジメトキシ―3,4―
ジヒドロナフタレン():アルゴン気流化5,
8―ジメトキシ―3,4―ジヒドロ―2―ナフト
エ酸(234mg、1.00m mole)をエーテル(10ml)
に懸濁し、これに氷浴中冷却撹拌下、メチルリチ
ウムのエーテル溶液(1.1m mole/ml、16ml、
17.6m mole)を30分で注入する。反応液は室温
で3時間撹拌後、充分に撹拌した5%塩酸水(40
ml)の中へ徐々に注入する。食塩を飽和させた
後、水溶液はエーテル(30ml×4)で抽出し、エ
ーテル抽出液は合せて、飽和重炭酸ナトリウム水
溶液(50ml×4)、10%チオ硫酸ナトリウム水溶
液(50ml)、水(50ml)、飽和食塩水(50ml)で順
次洗滌後、無水硫酸マグネシウムで乾燥した。
過濃縮すると淡黄色オイル(252mg)が得られ
た。得られた粗製オイルは薄層クロマトグラフイ
ー(シリカゲル、溶媒、ベンゼン―酢酸エチル
8:1)で分離精製し、を淡黄色結晶(172
mg、74%)として得た。イソプロピルエーテルよ
り再結晶し、純品のを淡黄色針状晶(125mg、
54%)、mp 104―105℃として得た。 IRνCHCl3 naxcm-1:1655(ケトン)。NMR(in
CDCl3):2.43(3H,s,COCH3),2.20―3.10
(4H,m,C ),3.77(3H,s,OC
),3.81(3H,s,OC )6.77(1H,
d,J=9.6Hz,one of aromatic protons),
6.88(1H,d,J=9.6Hz,one of aromatic
protons),7.83(1H,bs,=CH)Anal,Calcd.
for C14H16O3:C,72.39;H,6.94,Found;
C,72.43 ;H,6.89 実施例 1―1 2―(1′(RS)―ヒドロキシ)エチル―5,
8―ジメトキシ―3,4―ジヒドロナフタレン
():無水エタノール(55ml)に(1.16g、
5.0m mole)を溶解し、これにナトリウムボロヒ
ドリド(284mg、7.5m mole)を加えた。反応液
は室温で4時間撹拌した。水(2ml)を加えたの
ち、反応液は減圧濃縮し、濃縮液に酢酸エチル
(30ml)と飽和食塩水(20ml)を加え、有機層を
分取した。水層は酢酸エチル(15ml×3)で抽出
し、酢酸エチル層は合せて飽和食塩水(20ml)で
洗滌した。無水硫酸マグネシウムで乾燥したのち
過溜去すると、粗製のが淡黄色オイル(1.21
g、定量的収率)として得られた。このものは、
ヘキサンを加えると結晶化した。ヘキサン(40
ml)より再結晶すると純品のが無色結晶(1.09
g、93%)、mp77―78℃、として得られた。さら
にヘキサンより再結晶をくり返し、の分析サン
プルを無色結晶、mp78―79℃を得た。 IRνCHCl3 naxcm-1:3600,1260,1100(アルコ
ーー
ル)。NMR(in CDCl3):1.31(3H,d,J=6
Hz,CH(OH)C ),2.06―2.44(2H,m,
H2C=),2.44(1H,s,O),2.68―2.94
(2H,m,C 2CH2C=),3.71(6H,s,two
OC ),4.42(1H,q,J=6Hz,C
(OH))、6.60(2H,s,aromatic protons),
6.78(1H,brs,=C),Anal,Calcd for
C14H18O3:C,71.77;H,7.74。Found:C,
71.90;H,7.73。 実施例 1―2 (−)―2―(1′(S)―ヒドロキシ)エチル
―5,8―ジメトキシ―3,4―ジヒドロナフタ
レン(′):アルゴン気流下リチウムアルミニ
ウムヒドリド(1.44g、38m mole)をエーテル
(70ml)に懸濁し、これに(−)―1(R),2
(S)―N―メチルエフエドリン(K,
Nakajima,日本化学雑誌,81,1476(1960)。)
(mp86.5―87.5℃、〔α〕20 ―29.5゜(C=4.54、

タノール))(6.81g、38m mole)のエーテル溶
液(100ml)を加え、1時間撹拌下加熱還流し、
ついでN―エチルアニリン(9.21g、76m
mole)のエーテル溶液(60ml)を加え、さらに
1時間撹拌下加熱還流して還元試薬を調製した。
還元試薬のエーテル溶液を−78℃に冷却し、
(2.20g、9.47m mole)のエーテル溶液(200
ml)を徐々に加え、同温度で3時間撹拌反応し
た。反応終了後、1N―塩酸(152ml、152m
mole)を加え、酢酸エチル(150ml×2)で抽出
した。抽出液は合せて、1%塩酸水(150ml×
2)、5%重炭酸ナトリウム水溶液(150ml)、水
(150ml×3)、飽和食塩水(150ml)で順次洗滌
し、無水硫酸マグネシウムで乾燥した。過溜去
し、粗製の′を淡黄色結晶(2.58g、定量的収
率)、〔α〕20 −17.8゜(C=1.83、エタノール)

して得た。 このサンプルから下記に述べる操作により得ら
れた〔α〕20 ―20.5゜(C=1.07、エタノール)を
示す′を光学純度100%とすると、このサンプル
は光学純度87%である。得られた結晶をヘキサン
(130ml)より再結晶し、光学純度100%の純品の
′を無色針状晶(1.8g、81%)、mp88―89℃、
〔α〕20 ―20.5゜(C=1.07、エタノール)として
得た。 IRνCHCl3 naxcm-1:3600,1260,1100(アルコ

ル)。NMR(in CDCl3):1.32(3H,d,J=6
Hz,CH(OH)C ),2.00―2.36(2H,m,
2C=),2.12(1H,s,O),2.64―2.88
(2H,m,C 2CH2C=),3.74(6H,s,two
OC ),4.40(1H,q,J=6Hz,C
(OH),6.60(2H,s,aro matic protons),
6.72(1H,brs,=C),Anal。Calcd
C14H18O3:C,71.77;H,7.74。Found:C,
71.57;H,7.76。 一方、酢酸エチルで抽出した残りの1N―塩酸
層は、10%水酸化ナトリウム水溶液でアルカリ性
(PH>12)とし、酢酸エチル(150ml×2)で抽出
した。酢酸エチル抽出液は合せて、飽和食塩水
(150ml)で洗い、無水炭酸カリウムで乾燥した。
過、溜出すると(−)―1(R),2(S)―
N―メチルエフエドリンとN―エチルアニリンの
1:2混合物を淡黄色油状物(16.3g、定量的回
収率)として得た。 実施例 2―1 2(RS)―(1′(SR)―ヒドロキシ)エチル
―5,8―ジメトキシ―1,2,3,4―テトラ
ヒドロ―2(RS)―ナフトール():アルゴ
ン気流下(117mg、0.50m mole)およびバナジ
ウムオキシアセチルアセトネート(1.9mg、
0.007m mole)をベンゼン(10ml)に溶解し、こ
れに室温撹拌下t―ブチルハイドロパーオキシド
のベンゼン溶液(22mg/ml、2.5ml、0.60m
mole)を加え、室温で45分間撹拌した。反応終
了後ベンゼンを溜去すると粗製のとその1
(SR),2(SR)―アイソマーの混合物が不安定
な油状物として得られた。 この混合物は、そのNMRスペクトル(in
CDCl3)において1位のプロトンを4.50ppmと
4.41ppmに示し、その面積比からとその1
(SR)、2(SR)アイソマーの比は96:4と算出
された。この結果は1′の光学純度から算出した値
とよく一致した。粗製のとその1(SR),2
(SR)―アイソマーの混合物はテトラヒドロフラ
ン(5ml)に溶解し、この溶液をリチウムアルミ
ニウムヒドリド(38mg、1.0m mole)をテトラヒ
ドロフラン(5ml)に懸濁した懸濁液に注入し、
室温で4時間撹拌した。反応終了後、2N NaOH
溶液(10ml)を加えて有機層を分液し、水層は酢
酸エチル(15ml×3)で抽出した。抽出液は合せ
て水(15ml)、飽和食塩水(15ml)で洗滌し、無
水硫酸マグネシウムで乾燥した。過、溜去する
と粗製のが無色結晶(131mg)として得られ
た。このものを薄層クロマトグラフイー(シリカ
ゲル、溶媒、ベンゼン―酢酸エチル1:1)で分
離精製し、を無色結晶(108mg、86%)、mp138
―141℃として得た。ここに得たは、エーテル
より再結晶しての分析サンプルを無色針状晶、
mp145―146℃として得た。 IRνKBr naxcm-1:3340,1260,1100,1070(アル

ール)。 NMR(in CDCl3―CD3OD):1.26(3H,d,J
=6.0Hz,CH(OH)C )、1.30―2.05(2H,
m,CH2C 2C(OH)),2.70―3.00(4H,m,
CH2C(OH)CH2C ),3.20―3.80(3H,
m,C(O)CH3およびO)、3.76(3H,
s,OCH3),3.78(3H,s,OCH3),6.68
(2H,s,aromatic protons)。AnalCalcd
for C14H20O4:C,66.64;H,7.99。Found;
C,66.34;H,7.94。 実施例 2―2 (−)―2(R)―(1′(S)―ヒドロキシ)
エチル―5,8―ジメトキシ―1,2,3,4―
テトラヒドロ―2(R)―ナフトール(′):
アルゴン気流下、′(mp88―89℃、〔α〕20
20.5゜(C=1.07、エタノール))(703mg、3.00m
mole)およびバナジウム オキシアセチルアセ
トネート(11mg、0.042m mole)をベンゼン(55
ml)に溶解し、これに室温撹拌下、t―ブチルハ
イドロパーオキシドのベンゼン溶液(22mg/
ml)、13.5ml、3.3m mole)を加え、同温度で1.5
時間反応した。反応終了後、ベンゼンを溜去する
と、粗製の′とその1(R),2(R)アイソマ
ーの混合物が不安定な油状物として得られた。こ
れをテトラヒドロフラン(40ml)に溶解し、この
テトラヒドロフラン溶液をリチウムアルミニウム
ヒドリド(456mg、12m mole)をテトラヒドロフ
ラン(40ml)に懸濁した懸濁液に加え、室温で2
時間撹拌した。反応終了後、10%水酸化ナトリウ
ム水溶液(65ml)を加え、水層を酢酸エチル(50
ml×3)で抽出した。抽出液は合せて水(50ml×
3)、飽和食塩水(100ml)で洗滌し、無水硫酸マ
グネシウムで乾燥した。過溜去し、粗製′と
その2(S)―エピマーの混合物を無色結晶
(730mg、′から97%)として得た。 無色結晶(730mg)の一部(380mg)をカラムク
ロマトグラフイー(シリカゲル、溶媒、ベンゼン
―酢酸エチル1:1)で分離精製し、′とその
2(S)―エピマーの混合物を無色針状晶(325
mg、′から82%)、mp140―150℃、〔α〕20
39.3゜(C=1.04、エタノール)として得た。こ
のもののIRおよびNMRスペクトルは、下記の純
品の′のものに一致した。このものから光学純
度90%の1′が得られるので、′とその2(S)
―エピマーの比率、すなわち、′とその1
(R),2(R)―エピマーの比率は、95:5と算
出された。 無色結晶(730mg)の残り(350mg)は、エーテ
ル(35ml)より結晶して、純品の′を無色針状
晶(252mg、70%)、mp154―155℃、〔α〕20
49.7゜(C=0.50、エタノール)として得た。IR
νCHCl3 naxcm-1:3580,1260,1105,1090(ア
ルコー
ル)。IRνKBr naxcm-1:3360,1260,1085(アル
コー
ル)NMR(in CDCl3―CD3OD):1.23(3H,
d,J=6Hz,CH(OH)C ),1.40―2.05
(2H,m,C 2C(OH))、2.50―2.88(4H,
m,CH2C(OH)CH2C ),3.20(2H,s,
XZ),3.62(1H,q,J=6Hz,C
(OH)CH3),3.72(3H,s,OC ),3.74
(3H,s,OC ),6.60(2H,s,aromatic
protons)。Anal,Calcd,for C14H20O4:C,
66.64;H,7.99。Found:C,66.48;H,
8.06。 実施例 3―1 2(RS)―アセチル―5,8―ジメトキシ―
1,2,3,4―テトラヒドロ―2(RS)―ナ
フトール(1):a)(101mg、0.40m mole)をベ
ンゼン(10ml)に溶解し、炭酸銀―セライト試薬
(Fetizon試薬)(1m mole/g、2.0m mole)を
加え、30分間加熱還流した。反応終了後、銀―セ
ライトを取し、ベンゼン(50ml)で洗滌した。
洗液は合せて、減圧溜去し、赤褐色固体(100
mg)を得た。これを薄層クロマトグラフイー(シ
リカゲル、溶媒、ベンゼン:酢酸エチル5:1)
にて分離精製し、1を無色結晶(90mg、90%)と
した得た。このものをクロロホルム―エーテルか
ら再結晶して純品の1を無色針状晶、mp100―
101℃(C,M,Wong,etal,Can.J.Chem,
49,2712(1971)。,mp100―102℃;T.H.
Smith,etalJ,Org Chem,42,3653
(1977)。,mp97℃)として得た。IRνnujol na
cm-1
1700(ケトン)。 NMR(in CDCl3):1.85〜2.10(2H,m,CH2C
2C(OH)CH2),2.30(3H,s,CO C
),2.70―3.00(4H,m,C 2CH2C(OH)C
),3.67(1H,s,O),3.72(3H,s,
OC ),3.76(3H,s,OCH3),6.58(2H,
s,aromatic protons)。このNMRスペクトル
は、文献(S,Terashima,etal,Chem
Pharm,Bull(Tokyo),27,2351(1979)。)に
一致した。 b)(50.5mg、0.20m mole)をジメチルス
ルホキシド(1ml)に溶解し、これに室温撹拌下
ピリジン(15.8mg、0.20m mole)のベンゼン溶
液(1ml)、トリフルオロ酢酸(11.4mg、0.10m
mole)のベンゼン溶液(1ml)およびジシクロ
ヘキシルカルボジイミド(124mg、0.60m mole)
を加え、同温度で39時間反応した。析出した白色
固体を去し、ベンゼンで洗滌した。洗液は合
せて、水(10ml×3)、飽和食塩水(10ml)で洗
滌し、無水硫酸マグネシウムで乾燥した。過、
溜去すると、油状物が得られた。このものを薄層
クロマトグラフイー(シリカゲル、溶媒、酢酸エ
チル:ベンゼン1:5)で分離精製し、1を半固
体(30.4mg、61%)として得た。このものをクロ
ロホルム―エーテルから再結晶すると、純品の1
を無色針状晶、mp100―101℃として得た。この
サンプルのスペクトルは、a)で得たサンプルの
ものと一致した。 実施例 3―2 (−)―2(R)―アセチル―5,8―ジメト
キシ―1,2,3,4―テトラヒドロ―2(R)
―ナフトール1′:′とその2(S)―エピマー
の混合物(mp140―150℃、〔α〕20 ―39.3゜(C
=1.04、エタノール))(135mg、0.54m mole)を
ベンゼン(13ml)に溶解し、Fetizon試薬(1m
mole/g、2.7g、2.7m mole)を加え、30分間
加熱還流した。反応終了後、銀―セライトを取
し、ベンゼン(40ml)で洗滌した。洗液は合せ
て減圧濃縮し、赤褐色オイル(140mg)を得た。
これを薄層クロマトグラフイー(シリカゲル、溶
媒、ベンゼン―酢酸エチル5:1)で分離精製
し、1′を無色結晶(105mg、84%)、mp123―127
℃、〔α〕20 ―42.5゜(C=0.89、クロロホルム)
として得た。このもののIRおよびNMRスペクト
ルは下記のものに一致した。また、〔α〕20
47.10(C=1.11、クロロホルム)を示す1′を光学
純度100%とすると、このものは光学純度90%で
ある。 一方、純品の′(mp154―155℃、〔α〕20
49.6゜(C=1.08、エタノール)(134mg、0.53m
mole)についても上記と同様に処理し、ベンゼ
ン洗液を減圧濃縮すると、赤褐色オイル(130
mg)が得られた。このものを上記と同様に薄層ク
ロマトグラフイーで分離精製し、純品の1′を無色
結晶(91mg、69%)、mp127―128.5℃、〔α〕20
44.0゜(C=1.92、クロロホルム)、として得
た。このものをクロロホルム―エーテルより2回
再結晶すると、1′の元素分析サンプルが無色針状
晶、mp128―129℃、〔α〕20 ―47.1゜(C=1.11、
クロロホルム)(S,Terashima,etal,Chem
Pharm Bull(Tokyo),27,2351(1979)。
mp128―129℃、〔α〕20 ―48.2゜(C=0.982、ク
ロロホルム))として得られた。IRνCHCl 3nax
cm-1
1710(ケトン)。NMR(in CDCl3):1.86―2.10
(2H,m,C 2C(OH))、2.29(3H,s,CO
),2.70―3.10(4H,m,C 2CH2C
(OH)C ),3.58(1H,s,O)、3.72
(3H,s,O C )3.76(3H,s,OC
),6.62(2H,s,aromatic protons)。これ
らのスペクトルは文献(S,Terashima,etal
Chem.Pharm,Bull(Tokyo),27,2351
(1979)。)に一致した。
A reduction reaction to the formula is used. Typically, lithium aluminum hydride, sodium bis(methoxyethoxy)aluminum hydride, etc. are used as a reducing agent in a solvent such as an ether solvent such as tetrahydrofuran, or an aromatic hydrocarbon solvent such as benzene or toluene.
React at ~+25°C for 1-4 hours. When optically active compound (') is subjected to this reduction reaction, optically active compound (') is obtained. Usually, when this reduction reaction is carried out using a compound (') mixed with a small amount of 1(R), 2(R)-isomer, 2
Compound (') mixed with (S)-epimer is obtained, and this crude product can be purified by means such as column chromatography and recrystallization. Further, the mixture containing the 2(S)-epimer can be subjected to the next oxidation reaction as it is. The fourth step is the step of oxidizing the 1'-hydroxy moiety (〓CHOH) of the compound (), but this oxidation reaction usually oxidizes the secondary alcohol to a ketone (〓
The CHOH→〓C=O) method is used. Oxidizing agents usually include chromic acid-sulfuric acid, pyridinium chlorochromate (E, J. Corey, et al .
Tetrahedron Letters, 1975 , 2647. ), dimethyl sulfoxide-dicyclohexylcarbodiimide trifluoroacetic acid-pyridine (K, E,
Pfitzner, etal , J. Am Chem Soc, 87 ,
5661, 5670 (1965). ), silver carbonate-celite,
(Fetizon reagent) (Fetizon, etal , J, Org.
Chem, 36 , 1339 (1971). ), etc., and the reaction is usually carried out in a solvent such as acetone, dichloromethane, dimethyl sulfoxide, benzene, etc. at 0 to 80°C for 1 to 24 hours. When optically active compound (') is oxidized with Fetizon reagent, optically active compound (1') of the present invention is obtained. When a compound (') mixed with the 2(S)-epimer as described above is used, a compound (1') mixed with the 2(S)-epimer of compound (1') is obtained. As described above, according to the present invention, anthracycline antibiotics can be synthesized from 2-acetyl-5,8-dimethoxy-3,4-dihydronaphthalene () by a simple reaction procedure that is industrially possible. 2-acetyl-5,8-dimethoxy-1,2,3,4- which can be an extremely useful starting material
Tetrahydro-2-naphthol (1) can be produced.
In particular, the optically active form (1') of compound (1) has an optical purity of 100.
%. The compound () is 5,8-dimethoxy-3,4-dihydro-2-naphthoic acid (S, Terashi-ma, Chem, Pharm, Bull,
(Tokyo), 27 , 2351 (1979). ) can be easily manufactured from That is, the present invention has the following advantages from an industrial standpoint.
This is an excellent synthesis method. Aspects of the present invention will be illustrated below with examples. Reference example 2-acetyl-5,8-dimethoxy-3,4-
Dihydronaphthalene (): Argon gas flow 5,
8-dimethoxy-3,4-dihydro-2-naphthoic acid (234mg, 1.00m mole) in ether (10ml)
An ether solution of methyllithium (1.1 mmole/ml, 16 ml,
17.6m mole) in 30 minutes. The reaction solution was stirred at room temperature for 3 hours, then thoroughly stirred with 5% hydrochloric acid (40%
ml). After saturating the salt, the aqueous solution was extracted with ether (30 ml x 4), and the ether extracts were combined with saturated sodium bicarbonate aqueous solution (50 ml x 4), 10% sodium thiosulfate aqueous solution (50 ml), and water (50 ml). ) and saturated brine (50 ml), and dried over anhydrous magnesium sulfate.
Overconcentration gave a pale yellow oil (252 mg). The obtained crude oil was separated and purified by thin layer chromatography (silica gel, solvent, benzene-ethyl acetate 8:1), and pale yellow crystals (172
mg, 74%). Recrystallized from isopropyl ether to give pure pale yellow needle crystals (125mg,
54%), mp 104-105°C. IRν CHCl3 nax cm -1 : 1655 (ketone). NMR (in
CDCl 3 ): 2.43 (3H, s, COCH 3 ), 2.20-3.10
(4H, m, C H 2 C H 2 ), 3.77 (3H, s, OC
H 3 ), 3.81 (3H, s, OC H 3 ) 6.77 (1H,
d, J=9.6Hz, one of aromatic protons),
6.88 (1H, d, J=9.6Hz, one of aromatic
protons), 7.83 (1H, bs, = CH) Anal, Calcd.
for C 14 H 16 O 3 :C, 72.39; H, 6.94, Found;
C, 72.43; H, 6.89 Example 1-1 2-(1′(RS)-hydroxy)ethyl-5,
8-Dimethoxy-3,4-dihydronaphthalene (): (1.16 g,
5.0 mmole) was dissolved, and sodium borohydride (284 mg, 7.5 mmole) was added thereto. The reaction solution was stirred at room temperature for 4 hours. After adding water (2 ml), the reaction solution was concentrated under reduced pressure, ethyl acetate (30 ml) and saturated brine (20 ml) were added to the concentrated solution, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (15 ml x 3), and the ethyl acetate layers were combined and washed with saturated brine (20 ml). After drying with anhydrous magnesium sulfate and over-distillation, the crude product is a pale yellow oil (1.21
g, quantitative yield). This thing is
Crystallization occurred when hexane was added. Hexane (40
ml), pure colorless crystals (1.09
g, 93%), mp77-78°C. Further recrystallization from hexane was repeated to obtain an analytical sample of colorless crystals, mp 78-79°C. IRν CHCl3 nax cm -1 : 3600, 1260, 1100 (alcohol). NMR (in CDCl 3 ): 1.31 (3H, d, J=6
Hz, CH( OH ) CH3 ), 2.06-2.44(2H, m,
C H 2 C=), 2.44 (1H, s, O H ), 2.68-2.94
(2H, m, CH 2 CH 2 C=), 3.71 (6H, s, two
OC H 3 ), 4.42 (1H, q, J = 6Hz, C H
(OH)), 6.60 (2H, s, aromatic protons),
6.78 (1H, brs, = CH ), Anal , Calcd for
C14H18O3 : C, 71.77 ; H, 7.74. Found:C,
71.90; H, 7.73. Example 1-2 (-)-2-(1'(S)-hydroxy)ethyl-5,8-dimethoxy-3,4-dihydronaphthalene ('): Lithium aluminum hydride (1.44 g, 38 mmole) under argon stream ) was suspended in ether (70 ml), and (-)-1(R),2
(S)-N-methylefedrine (K,
Nakajima, Japanese Chemical Journal, 81 , 1476 (1960). )
(mp86.5-87.5℃, [α] 20D - 29.5゜(C=4.54,
An ether solution (100 ml) of methanol) (6.81 g, 38 mmole) was added, and the mixture was heated to reflux with stirring for 1 hour.
Then N-ethylaniline (9.21g, 76m
A reducing reagent was prepared by adding an ether solution (60 ml) of mol.
The ether solution of the reducing reagent was cooled to −78°C,
(2.20g, 9.47m mole) in ether solution (200
ml) was gradually added, and the mixture was stirred and reacted at the same temperature for 3 hours. After the reaction, add 1N-hydrochloric acid (152ml, 152m
mole) and extracted with ethyl acetate (150 ml x 2). Combine the extracts and add 1% hydrochloric acid water (150ml x
2) Washed sequentially with 5% aqueous sodium bicarbonate solution (150 ml), water (150 ml x 3), and saturated brine (150 ml), and dried over anhydrous magnesium sulfate. After distillation, the crude ' was obtained as pale yellow crystals (2.58 g, quantitative yield), [α] 20 D -17.8° (C = 1.83, ethanol).
obtained as. Assuming that the optical purity of [α] 20 D −20.5° (C=1.07, ethanol) obtained from this sample by the procedure described below is 100%, the optical purity of this sample is 87%. The obtained crystals were recrystallized from hexane (130 ml), and the pure product with optical purity of 100% was converted into colorless needle crystals (1.8 g, 81%), mp88-89℃,
[α] 20 D -20.5° (C=1.07, ethanol) was obtained. IRν CHCl3 nax cm -1 : 3600, 1260, 1100 (alcohol). NMR (in CDCl 3 ): 1.32 (3H, d, J=6
Hz, CH( OH ) CH3 ), 2.00-2.36(2H, m,
C H 2 C=), 2.12 (1H, s, O H ), 2.64-2.88
(2H, m, CH 2 CH 2 C=), 3.74 (6H, s, two
OC H3 ), 4.40 ( 1H , q, J=6Hz, C H
(OH), 6.60 (2H, s, aromatic protons),
6.72 (1H, brs, = C H ), Anal . Calcd
C14H18O3 : C, 71.77 ; H, 7.74. Found:C,
71.57; H, 7.76. On the other hand, the remaining 1N-hydrochloric acid layer extracted with ethyl acetate was made alkaline (PH > 12) with a 10% aqueous sodium hydroxide solution and extracted with ethyl acetate (150 ml x 2). The ethyl acetate extracts were combined, washed with saturated brine (150 ml), and dried over anhydrous potassium carbonate.
When filtered and distilled, (-)-1(R), 2(S)-
A 1:2 mixture of N-methylefedrin and N-ethylaniline was obtained as a pale yellow oil (16.3 g, quantitative recovery). Example 2-1 2(RS)-(1'(SR)-hydroxy)ethyl-5,8-dimethoxy-1,2,3,4-tetrahydro-2(RS)-naphthol (): Under argon stream ( 117mg, 0.50m mole) and vanadium oxyacetylacetonate (1.9mg,
0.007m mole) was dissolved in benzene (10ml), and a benzene solution of t-butyl hydroperoxide (22mg/ml, 2.5ml, 0.60ml) was added to this under stirring at room temperature.
mole) and stirred at room temperature for 45 minutes. When the benzene is distilled off after the reaction is completed, crude product 1 is obtained.
A mixture of (SR), 2(SR)-isomers was obtained as an unstable oil. This mixture shows its NMR spectrum (in
The first proton in CDCl 3 ) is 4.50ppm.
4.41ppm, and from the area ratio and part 1
(SR), 2 (SR) isomer ratio was calculated to be 96:4. This result agreed well with the value calculated from the optical purity of 1'. Crude tomato part 1 (SR), 2
The mixture of (SR)-isomers was dissolved in tetrahydrofuran (5 ml) and this solution was injected into a suspension of lithium aluminum hydride (38 mg, 1.0 mmole) in tetrahydrofuran (5 ml).
Stirred at room temperature for 4 hours. After the reaction is complete, add 2N NaOH
A solution (10 ml) was added to separate the organic layer, and the aqueous layer was extracted with ethyl acetate (15 ml x 3). The extracts were combined, washed with water (15 ml) and saturated brine (15 ml), and dried over anhydrous magnesium sulfate. After filtration and distillation, a crude product was obtained as colorless crystals (131 mg). This product was separated and purified by thin layer chromatography (silica gel, solvent, benzene-ethyl acetate 1:1), and colorless crystals (108 mg, 86%) were obtained.mp138
-141℃. The analysis sample obtained here was recrystallized from ether as colorless needle crystals.
Obtained as mp145-146℃. IRν KBr nax cm -1 : 3340, 1260, 1100, 1070 (alcohol). NMR (in CDCl 3 - CD 3 OD): 1.26 (3H, d, J
=6.0Hz, CH(OH) CH3 ), 1.30-2.05 (2H,
m, CH 2 C H 2 C (OH)), 2.70-3.00 (4H, m,
CH2C (OH) CH2CH2 ), 3.20―3.80 (3H ,
m, C H (OH) CH 3 and O H ) , 3.76 (3H,
s, OCH 3 ), 3.78 (3H, s, OCH 3 ), 6.68
(2H, s, aromatic protons). Anal . Calcd ,
for C 14 H 20 O 4 :C, 66.64; H, 7.99. Found;
C, 66.34; H, 7.94. Example 2-2 (-)-2(R)-(1'(S)-hydroxy)
Ethyl-5,8-dimethoxy-1,2,3,4-
Tetrahydro-2(R)-naphthol ('):
Under argon flow, '(mp88-89℃, [α] 20 D -
20.5゜(C=1.07, ethanol)) (703mg, 3.00m
benzene (55 m mole) and vanadium oxyacetylacetonate (11 mg, 0.042 m mole)
ml), and to this was added a benzene solution of t-butyl hydroperoxide (22 mg/mL) under stirring at room temperature.
ml), 13.5ml, 3.3m mole) and 1.5ml at the same temperature.
Time reacted. After the reaction was completed, benzene was distilled off to obtain a mixture of crude ' and its 1(R) and 2(R) isomers as an unstable oil. This was dissolved in tetrahydrofuran (40 ml), and this tetrahydrofuran solution was added to a suspension of lithium aluminum hydride (456 mg, 12 mmole) in tetrahydrofuran (40 ml).
Stir for hours. After the reaction was completed, 10% aqueous sodium hydroxide solution (65 ml) was added, and the aqueous layer was diluted with ethyl acetate (50 ml).
ml x 3). Combine the extract with water (50ml x
3) Washed with saturated brine (100 ml) and dried over anhydrous magnesium sulfate. After distillation, a mixture of crude ' and its 2(S)-epimer was obtained as colorless crystals (730 mg, 97% from '). A portion (380 mg) of the colorless crystals (730 mg) was separated and purified by column chromatography (silica gel, solvent, benzene-ethyl acetate 1:1), and a mixture of ' and its 2(S)-epimer was separated and purified as colorless needle-shaped crystals. (325
mg, 82% from '), mp140-150℃, [α] 20 D -
39.3° (C=1.04, ethanol). The IR and NMR spectra of this product matched those of the pure product '' below. Since 1′ with optical purity of 90% can be obtained from this product, ′ and its 2(S)
-Ratio of epimers, i.e. ' and its 1
The ratio of (R),2(R)-epimers was calculated to be 95:5. The remainder (350 mg) of the colorless crystals (730 mg) was crystallized from ether (35 ml) to obtain pure colorless needle crystals (252 mg, 70%), mp154-155℃, [α] 20 D -
49.7° (C=0.50, ethanol). IR
ν CHCl3 nax cm -1 : 3580, 1260, 1105, 1090 (alcohol). IRν KBr nax cm -1 : 3360, 1260, 1085 (alcohol) NMR (in CDCl 3 - CD 3 OD): 1.23 (3H,
d, J=6Hz, CH(OH) CH3 ), 1.40-2.05
(2H, m, C H 2 C (OH)), 2.50-2.88 (4H,
m, CH 2 C (OH) CH 2 C H 2 ), 3.20 (2H, s,
O H XZ), 3.62 (1H, q, J=6Hz, C H
(OH)CH 3 ), 3.72 (3H, s, OC H 3 ), 3.74
(3H, s, OC H 3 ), 6.60 (2H, s, aromatic
protons). Anal , Calcd, for C 14 H 20 O 4 :C,
66.64; H, 7.99. Found: C, 66.48; H,
8.06. Example 3-1 2(RS)-acetyl-5,8-dimethoxy-
1,2,3,4-tetrahydro-2(RS)-naphthol (1):a) (101 mg, 0.40 m mole) was dissolved in benzene (10 ml), silver carbonate-Celite reagent (Fetizon reagent) (1 m mole /g, 2.0 mmole) and heated under reflux for 30 minutes. After the reaction was completed, the silver-celite was removed and washed with benzene (50 ml).
The washing liquids were combined and distilled under reduced pressure to obtain a reddish brown solid (100
mg) was obtained. This was subjected to thin layer chromatography (silica gel, solvent, benzene:ethyl acetate 5:1).
Separation and purification was performed to obtain 1 as colorless crystals (90 mg, 90%). This product was recrystallized from chloroform-ether to produce pure 1 as colorless needle crystals, mp100-
101℃ (C, M, Wong, etal , Can.J.Chem,
49 , 2712 (1971). ,mp100-102℃;TH
Smith, etal J, Org Chem, 42 , 3653
(1977). , mp97℃). IRν nujol na
x
cm -1 :
1700 (ketones). NMR (in CDCl 3 ): 1.85-2.10 (2H, m, CH 2 C
H 2 C (OH) CH 2 ), 2.30 (3H, s, CO C H
3 ), 2.70-3.00 (4H, m, CH 2 CH 2 C(OH)C
H 2 ), 3.67 (1H, s, O H ), 3.72 (3H, s,
OC H 3 ), 3.76 (3H, s, OCH 3 ), 6.58 (2H,
s, aromatic protons). This NMR spectrum was obtained from the literature (S. Terashima et al ., Chem.
Pharm, Bull (Tokyo), 27 , 2351 (1979). ) matched. b) (50.5mg, 0.20m mole) was dissolved in dimethyl sulfoxide (1ml), and to this was added a benzene solution (1ml) of pyridine (15.8mg, 0.20m mole) and trifluoroacetic acid (11.4mg, 0.10m mole) under stirring at room temperature.
mole) in benzene (1 ml) and dicyclohexylcarbodiimide (124 mg, 0.60 m mole)
was added and reacted at the same temperature for 39 hours. The precipitated white solid was removed and washed with benzene. The washings were combined, washed with water (10 ml x 3) and saturated brine (10 ml), and dried over anhydrous magnesium sulfate. Too late,
Distillation gave an oil. This product was separated and purified by thin layer chromatography (silica gel, solvent, ethyl acetate:benzene 1:5) to obtain 1 as a semisolid (30.4 mg, 61%). When this product is recrystallized from chloroform-ether, pure 1
was obtained as colorless needle crystals, mp 100-101°C. The spectrum of this sample matched that of the sample obtained in a). Example 3-2 (-)-2(R)-acetyl-5,8-dimethoxy-1,2,3,4-tetrahydro-2(R)
-Mixture of naphthol 1':' and its 2(S)-epimer (mp140-150℃, [α] 20 D -39.3゜(C
= 1.04, ethanol) (135 mg, 0.54 m mole) was dissolved in benzene (13 ml) and Fetizon reagent (1 m
mole/g, 2.7 g, 2.7 mmole) was added, and the mixture was heated under reflux for 30 minutes. After the reaction was completed, the silver-celite was removed and washed with benzene (40 ml). The washing liquids were combined and concentrated under reduced pressure to obtain a reddish-brown oil (140 mg).
This was separated and purified by thin layer chromatography (silica gel, solvent, benzene-ethyl acetate 5:1), and 1' was obtained as colorless crystals (105 mg, 84%), mp123-127
°C, [α] 20 D -42.5° (C = 0.89, chloroform)
obtained as. The IR and NMR spectra of this product were consistent with those below. Also, [α] 20 D -
If 1' showing 47.10 (C=1.11, chloroform) has an optical purity of 100%, this product has an optical purity of 90%. On the other hand, pure product' (mp154-155℃, [α] 20D -
49.6゜(C=1.08, ethanol) (134mg, 0.53m
mole) was treated in the same manner as above, and the benzene washing solution was concentrated under reduced pressure, resulting in a reddish brown oil (130
mg) was obtained. This product was separated and purified by thin layer chromatography in the same manner as above, and pure 1' was obtained as colorless crystals (91 mg, 69%), mp127-128.5℃, [α] 20 D -
44.0° (C=1.92, chloroform). When this product was recrystallized twice from chloroform-ether, the elemental analysis sample of 1' was colorless needle crystals, mp 128-129℃, [α] 20 D -47.1゜ (C = 1.11,
Chloroform) (S, Terashima, etal , Chem
Pharm Bull (Tokyo), 27 , 2351 (1979).
mp128-129°C, [α] 20 D -48.2° (C=0.982, chloroform)). IRν CHCl 3nax
cm -1 :
1710 (ketone). NMR (in CDCl3 ): 1.86-2.10
(2H, m, C H 2 C (OH)), 2.29 (3H, s, CO
C H 3 ), 2.70-3.10 (4H, m, C H 2 CH 2 C
(OH) CH2 ) , 3.58 (1H,s, OH ), 3.72
(3H,s,OC H3 )3.76( 3H ,s,OC H
3 ), 6.62 (2H, s, aromatic protons). These spectra are from the literature (S, Terashima, et al.
Chem.Pharm, Bull (Tokyo), 27 , 2351
(1979). ) matched.

Claims (1)

【特許請求の範囲】 1 式 で示される2―アセチル―5,8―ジメトキシ―
3,4―ジヒドロナフタリンのカルボニル(〓
CO)部を還元し式 で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―3,4―ジヒドロナフタリンを
得、次いでこの化合物の1位2位間の二重結合を
エポキシ化し、式 で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―1,2―エポキシ―1,2,
3,4―テトラヒドロナフタリンを得、次いでこ
の化合物の1,2―エポキシ部【式】 を還元し、式 で示される2―(1′―ヒドロキシ)エチル―5,
8―ジメトキシ―1,2,3,4―テトラヒドロ
―2―ナフトールを得、次いでこの化合物の1′―
ヒドロキシ部(〓CHOH)を酸化することを特
徴とする式 で示される2―アセチル―5,8―ジメトキシ―
1,2,3,4―テトラヒドロ―2―ナフトール
の新規製造法2 式 で示される2―アセチル―5,8―ジメトキシ―
3,4―ジヒドロナフタリンのカルボニル(〓
CO)部を、(−)−1(R)、2(S)―N―アル
キルまたはアルアルキル置換エフエドリンとN―
モノアルキルまたはアリール置換アニリン類とで
部分分解したリチウムアルミニウムヒドリドで不
斉還元し、式 で示される(−)―2―(1′(S)―ヒドロキ
シ)エチル―5,8―ジメトキシ―3,4―ジヒ
ドロナフタリンを得、次いでこの化合物の1位2
位間の二重結合をエポキシ化し、式 で示される2(S)―(1′(S)―ヒドロキシ)
エチル―5,8―ジメトキシ―1(S)、2
(S)―エポキシ―1,2,3,4―テトラヒド
ロナフタリンを得、次いでこの化合物の1,2―
エポキシ部【式】を還元し、式 で示される(−)―2(R)―(1′(S)―ヒド
ロキシ)エチル―5,8―ジメトキシ―1,2,
3,4―テトラヒドロ―3(R)―ナフトールを
得、次いでこの化合物の1′―ヒドロキシ部(〓
CHOH)を酸化することを特徴とする式 で示される(−)―2(R)―アセチル―5,8
―ジメトキシ―1,2,3,4―テトラヒドロ―
2(R)―ナフトールの新規製造法。
[Claims] 1 formula 2-acetyl-5,8-dimethoxy represented by
Carbonyl of 3,4-dihydronaphthalene (〓
CO) part is reduced and the formula 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-3,4-dihydronaphthalene was obtained, and then the double bond between the 1st and 2nd positions of this compound was epoxidized to give the formula 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-1,2-epoxy-1,2,
3,4-tetrahydronaphthalene was obtained, and the 1,2-epoxy moiety [formula] of this compound was then reduced to give the formula 2-(1'-hydroxy)ethyl-5,
8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol is obtained, and then the 1'-
Formulas characterized by oxidizing the hydroxy moiety (〓CHOH) 2-acetyl-5,8-dimethoxy represented by
New method for producing 1,2,3,4-tetrahydro-2-naphthol 2 Formula 2-acetyl-5,8-dimethoxy represented by
Carbonyl of 3,4-dihydronaphthalene (〓
CO) moiety with (-)-1(R), 2(S)-N-alkyl- or aralkyl-substituted ephedrin and N-
Asymmetric reduction with lithium aluminum hydride partially decomposed with monoalkyl- or aryl-substituted anilines gives the formula (-)-2-(1'(S)-hydroxy)ethyl-5,8-dimethoxy-3,4-dihydronaphthalene represented by
By epoxidizing the double bond between the positions, the formula 2(S)-(1'(S)-hydroxy) represented by
Ethyl-5,8-dimethoxy-1(S),2
(S)-epoxy-1,2,3,4-tetrahydronaphthalene was obtained, and then the 1,2-
Reducing the epoxy part [formula], the formula (-)-2(R)-(1'(S)-hydroxy)ethyl-5,8-dimethoxy-1,2,
3,4-tetrahydro-3(R)-naphthol was obtained, and then the 1'-hydroxy moiety (〓
A formula characterized by oxidizing CHOH) (-)-2(R)-acetyl-5,8 represented by
-dimethoxy-1,2,3,4-tetrahydro-
A new method for producing 2(R)-naphthol.
JP2767380A 1980-03-04 1980-03-04 Novel preparation of 2-acetyl-5,8-demethoxy-1,2,3,4- tetrahydro-2-naphthol Granted JPS56123931A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2767380A JPS56123931A (en) 1980-03-04 1980-03-04 Novel preparation of 2-acetyl-5,8-demethoxy-1,2,3,4- tetrahydro-2-naphthol
EP81300754A EP0035355B1 (en) 1980-03-04 1981-02-24 Modified aluminium hydrides, their preparation and their use in reducing acetylnaphthalene derivatives
DE8181300754T DE3163452D1 (en) 1980-03-04 1981-02-24 Modified aluminium hydrides, their preparation and their use in reducing acetylnaphthalene derivatives
US06/238,136 US4338255A (en) 1980-03-04 1981-02-25 Modified lithium aluminum hydrides
CA000372229A CA1142950A (en) 1980-03-04 1981-03-03 Modified lithium aluminum hydrides
US06/363,048 US4418218A (en) 1980-03-04 1982-03-29 Process for producing dihydronaphthalene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767380A JPS56123931A (en) 1980-03-04 1980-03-04 Novel preparation of 2-acetyl-5,8-demethoxy-1,2,3,4- tetrahydro-2-naphthol

Publications (2)

Publication Number Publication Date
JPS56123931A JPS56123931A (en) 1981-09-29
JPS6241586B2 true JPS6241586B2 (en) 1987-09-03

Family

ID=12227464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2767380A Granted JPS56123931A (en) 1980-03-04 1980-03-04 Novel preparation of 2-acetyl-5,8-demethoxy-1,2,3,4- tetrahydro-2-naphthol

Country Status (1)

Country Link
JP (1) JPS56123931A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111598U (en) * 1989-02-22 1990-09-06
JPH02148394U (en) * 1989-05-19 1990-12-17

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2630122B2 (en) * 1991-06-28 1997-07-16 三菱電機株式会社 Blower wing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111598U (en) * 1989-02-22 1990-09-06
JPH02148394U (en) * 1989-05-19 1990-12-17

Also Published As

Publication number Publication date
JPS56123931A (en) 1981-09-29

Similar Documents

Publication Publication Date Title
DE60208790T2 (en) PROCESS FOR PREPARING DIHYDROXY DERIVATIVES AND EPOXY RESIN THEREOF
Patrick et al. Stereospecific vicinal oxyamination of olefins by alkylimidoosmium compounds
Bravo et al. New fluorinated chiral synthons
US4127608A (en) Synthesis of Vitamin E
JPS6241586B2 (en)
US4310465A (en) Synthesis of vitamin E and quinone intermediates
EP0168175B1 (en) Preparation of tamoxifen
Woolsey et al. Epoxydiazo ketones. Synthesis and reactions
Edwards et al. Gem-dimethylcyclopropanation using triisopropylsulfoxonium tetrafluoroborate: scope and limitations
EP0129252B1 (en) Process for the preparation of optically active hydroquinone derivatives and of d-alpha-tocopherol
US4433159A (en) Synthesis of optically active d-alpha tocopherol
Mao et al. Total synthesis of panaxydol and its stereoisomers as potential anticancer agents
US4185154A (en) Synthesis of vitamin E
Tsuchihashi et al. Reaction of α-Chloro Sulfoxides with Carbonyl and Thiocarbonyl Compounds
EP0035355B1 (en) Modified aluminium hydrides, their preparation and their use in reducing acetylnaphthalene derivatives
US4243598A (en) Synthesis of vitamin E
KR100669167B1 (en) Process for the preparation of coenzyme Qn and intermediates thereof
FR2472572A1 (en) NOVEL POLYCYCLIC COMPOUNDS DERIVED FROM ANTHRACENE AND NAPHTHACENE AND PROCESS FOR THEIR PREPARATION
Krauss et al. Intramolecular Oxidative Coupling of Aromatic Compounds. I. Oxidation of Diphenolic Substrates
CN121226224A (en) A method for synthesizing perfluoroalkyl-substituted indole
JPS6118734A (en) Production of lignan
CA1239647A (en) INTERMEDIATE FOR THE SYNTHESIS OF OPTICALLY ACTIVE D- .alpha. TOCOPHEROL
FR2641784A1 (en) PROCESS FOR PREPARING CHROMAN DERIVATIVES AND SYNTHETIC INTERMEDIATES
CN117800820A (en) Preparation method of 4-pentanone aldehyde
KR100570279B1 (en) Intermediates of coenzyme Qn and methods for preparing the intermediate